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Chronic ingestion of saturated fatty acids (SFAs) was previously shown to compromise blood-brain barrier integrity, leading to
brain parenchymal extravasation of apolipoprotein B (apo B) lipoproteins enriched in amyloid beta. In contrast, diets enriched in
mono-orpolyunsaturated(PUFA)oilshadnodetrimentaleﬀect.Rather,n3andn6oilsgenerallyconferprotectionviasuppression
of inﬂammation. This study investigated in wild-type mice if a PUFA diet enriched in docosahexanoic acid (DHA) restored blood-
brainbarrierintegrityandattenuatedparenchymalapoBabundanceinducedbychronicingestionofSFA.Cerebrovascularleakage
ofapo B was quantitated utilisingimmunoﬂuorescent staining.Theplasmaconcentration of brain-derived S100β was measuredas
a marker of cerebrovascular inﬂammation. In mice fed SFA for 3 months, provision thereafter of a DHA-enriched diet exacerbated
parenchymal apo B retention, concomitant with a signiﬁcant increase in plasma cholesterol. In contrast, provision of a low-fat diet
following chronic SFA feeding had no eﬀect on SFA-induced parenchymal apo B. The ﬁndings suggest that in a heightened state of
cerebrovascular inﬂammation, the provision of unsaturated fatty acids may be detrimental, possibly as a consequence of a greater
susceptibility for oxidation.
1.Introduction
Accumulating evidence supports the hypothesis that dietary
behaviour and in particular ingestion of fats contribute to
Alzheimer’s disease (AD) onset and progression. The work
in [1] reported that the prevalence of sporadic and late-onset
AD in >65 years of age subjects correlated with fat intake and
was higher in Western countries, compared to Africa or Asia.
Population and clinical studies also suggest that regular con-
sumptionofsaturatedfattyacids(SFAs)andtrans-fattyacids
as well as cholesterol is synergistically and positively associ-
ated with increased risk of AD [1, 2] through mechanisms
that include dyslipidemia, endothelial dysfunction, inﬂam-
mation, and oxidative stress. In contrast, populations with
greater consumption of fats as poly- or mono-unsaturated
oils (PUFA and MUFA, resp.) have lower prevalence of AD
and vascular based dementias [1–4], probably as a con-
sequence of lower levels of systemic inﬂammation [5–7].
In AD, chronic inﬂammation leading to neuronal loss
appears to be primarily associated with cerebrovascular
and brain parenchymal deposits of amyloid beta (Aβ)[ 8].
D e r i v e df r o mt h ea m y l o i dp r e c u r s o rp r o t e i n ,A β is the pre-
dominant component of “amyloid” (or senile) plaques [9,
10]. Key triggers of cerebrovascular amyloidosis are thought
to include enhanced proteolytic processing of the precursor
protein on the plasma membrane of neuronal cells [11–
13], a phenomenon more common in early-onset AD. In
addition, ﬁbrillar formation of Aβ and deposition upon
extracellular matrices may also reﬂect decreased degradation
and eﬄux by epithelial cells of the choroid plexus [14,
15]. Alternatively, cerebral parenchymal Aβ load may be
exacerbated if cerebrovascular integrity is compromised and2 International Journal of Vascular Medicine
blood-to-brain delivery of peripheral Aβ is increased [16,
17]. Moreover, the latter typically results in the activation of
astro-glial cells and oxidation of proteins and lipids [18, 19].
Signiﬁcant plasma Aβ is found associated with triglyc-
eride-richlipoproteins(TRLs)andcellcultureandimmuno-
histochemical studies conﬁrm secretion of Aβ as a TRL from
hepatocytes and absorptive epithelial cells of the small
intestine [20–22]. In humans there is a transient increase in
plasma Aβ concentration, following the consumption of a
mixed lipid meal and kinetic studies in vivo showing that Aβ
serves as a regulating apolipoprotein of TRLs [23]. However,
several lines of evidence suggest that persistent disturbances
in the TRL-Aβ pathway may contribute to AD risk. In three
strains of amyloid transgenic mice, secretion into plasma of
TRL-Aβ was strongly associated with onset and progression
of amyloidosis [24]. Moreover, signiﬁcant cerebrovascular
disturbances were reported preceding plaque formation in
amyloid transgenic mice [25]. Consistent with the concept of
disease induction in response to exaggerated exposure, sub-
jects with AD were reported to have signiﬁcantly elevated
plasma TRL-Aβ concomitant with evidence postprandial dy-
slipidaemia [26]. Moreover, in human cadaver and in trans-
genic-amyloid mice brain specimens, signiﬁcant apolipopro-
tein B (apo B) immunoreactivity colocalized with early dif-
fused amyloid plaque [27, 28].
Toexploredirectlythehypothesisofadietaryfatmodula-
tion of TRL-Aβ and cerebrovascular integrity axis, wild-type
(WT) mice were fed diets enriched in either SFA, MUFA, or
PUFAs [28]. Within 12 weeks of dietary intervention, mice
maintained on the SFA diet showed substantial parenchymal
extravasation of plasma proteins including apo B lipopro-
teins enriched with Aβ. The endothelial tight junction pro-
tein occludin was substantially attenuated in SFA-fed mice
concomitant with substantially increased enterocytic abun-
dance of Aβ [28, 29]. In contrast, mice maintained on either
the MUFA or PUFA diets had no cerebrovascularaberrations
and penetration of plasma proteins in these two groups was
comparable to low-fat- (LF-) fed controls.
The potential cytotoxic properties of SFA are established
and the principal mechanisms include mitochondrial respi-
ratoryburstresultinginoxidativestressandendoplasmicret-
iculum dysfunction [30]. Polyunsaturates on the other hand
and in particular docosahexanoic acid (DHA) generally an-
tagonise the eﬀects of SFA and are purported to confer cyto-
protection because of potent anti-inﬂammatory eﬀects [5,
31–33]. However, unsaturated fatty acids such as DHA are
highly susceptible to lipid peroxidation and if inﬂammation
is already established, then oxidative damage may be para-
doxically ampliﬁed with the provision of unsaturated fatty
acids such as DHA. To explore the hypothesis that poly-
unsaturated fatty acids confer beneﬁt and not risk in a cere-
brovascular proinﬂammatory state, we explored parenchy-
mal extravasation of apo B lipoproteins in WT mice initially
maintained on an SFA-enriched diet for 3 months, followed
by randomization to either an LF- or a PUFA-enriched diet
for 2 months.
2. Methods
2.1. Animals and Diet Conditions. The animal housing,
handling, and experimental procedures described for this
study were approved by the Curtin University Animal Exper-
imentation and Ethics Committee. Six-week-old female WT
mice (C57BL/6J) were housed in groups and randomized
into their respective diets (n = 6 mice per group). All mice
weremaintained ona 12hlightand darkcycleroom, at22◦C
a n dw i t hf r e ea c c e s st ow a t e ra n df o o d .
Mice were fed an SFA diet (SF07-050, Glen Forrest
Stockfeeders, Glen Forrest, Western Australia) for 3 months
and then randomised to receive either an LF (AIN-93M,
Glen Forrest Stockfeeders), PUFA-enriched (SF07-049, Glen
Forrest Stockfeeders), or maintained on SFA for a further 2
months. Fatty acid composition for each diet is shown in
Table 1. Digestible energy for the SFA diet was 18.8MJ/kg
and contained palmitic (16:0) and stearic (18:0) as the
principle saturated fats (13%, w/w). The LF diet contained
4% (w/w) as total fat and 15.1MJ/kg of digestible energy
and only <1% of total digestible energy from lipids. The
PUFA diet contained 8.22% (w/w) of DHA and 2.00% (w/w)
eicosapentaenoic acid (EPA) sourced from NUMEGA ﬁsh
oil. The diet generated 18.8MJ/kg of digestible energy where
40% of energy derived from lipids. All diets had suﬃcient
essential fatty acids.
2.2. Tissue Collection and Sample Preparation. Blood and
brain samples were collected as previously described by
Takechi et al. [28]. Mice were anaesthetised with pentobarbi-
tone (45mg/kg i.p.), and exsanguinated by cardiac puncture.
Blood was collected into K-2 EDTA tubes and stored in ice.
Plasma was separated by short speed centrifugation at 4◦C
a n ds t o r e da t−80◦C.
Brain tissues were carefully isolated, washed with chilled
phosphate buﬀer saline (PBS, pH 7.4), right hemispheres
were separated, and ﬁxed in 4% paraformaldehyde for
24h. The tissues were then cryoprotected with 20% sucrose
solutionat4◦Cfor72h,frozeninisopentanewithdryiceand
stored at −80◦C. For histology and ﬂuorescence microscopy,
serial cryosections of 18μm were cut from the right cerebral
hemispheres for each mouse and mounted on Polysine slides
(LabServ, Australia).
2.3. Cerebral Apo B Immunoﬂuorescence. Cerebrovascular
leakage of apo B was detected as previously described
[28]. Brain cryosections (18μm) were air-dried for 30min,
rehydrated with PBS and incubated in blocking serum
(10% goat serum) for 30min prior to the application of
the antibodies. Cerebral apo B was detected by overnight
incubationwiththeprimaryantibodypolyclonalrabbitanti-
apo B (ab20737, Abcam, Cambridge, UK) at 1:500 dilution,
at 4◦C. Postovernight incubation and washing with PBS,
primary antibody was labelled at room temperature with the
secondarygoatanti-rabbitIgG-Alexa488ﬂuorochromecon-
jugate (A-11034, Invitrogen) for 2h. The sections were then
washed with PBS and the nuclei were counterstained with
DAPI (1:1000) for 5min at room temperature. Thereafter,
the stained sections were mounted with antifade mountingInternational Journal of Vascular Medicine 3
Table 1: Dietary composition.
SFA diet LF diet DHA diet
Calculated nutritional parameters (%)
Protein 13.6 13.6 13.6
Total fat 20.3 4 20.3
Crude ﬁbre 4.7 4.7 4.7
Acid detergent Fibre 4.7 4.7 4.7
Digestible energy 18.8MJ/kg 15.1MJ/kg 18.8MJ/kg
% Digestible energy from lipids 40 n/a 40
% Digestible energy from protein 15 n/a 15
Calculated fat composition (%)
Myristic acid 14:0 0.05 Trace 0.54
Pentadecanoic acid 15:0 0.01 n/a 0.16
Palmitic acid 16:0 5.16 0.2 3.26
Megaric acid 17:0 0.05 n/a 0.18
Stearic acid 18:0 7.31 0.1 0.92
Arachidic acid 20:0 0.24 n/a 0.06
Behenic acid 22:0 0.04 n/a 0.05
Tetracosanoic acid 24:0 0.03 n/a 0.05
Palmitoleic acid 16:1 0.05 Trace 0.66
Heptadecenoic acid 17:1 0.01 n/a 0.10
Oleic acid 18:1 n9 6.62 2.4 2.25
Gadoleic acid 20:1 0.01 n/a 0.18
Lenoleic acid 18:2 n6 0.67 0.8 0.23
a Linolenic acid 18:3 n3 0.05 0.4 0.09
g Linolenic acid 18:3 n6 Not detected n/a 0.08
Arachadonic acid 20:4 n6 Not detected Trace 0.46
EPA 20:5 n3 Not detected Trace 2.00
DHA 22:6 n3 Not detected Trace 8.22
The total fatty acid composition of SFA, LF, and DHA diets. Vitamin and mineral contents were balanced in all diets.
medium. Primary antibody was replaced with buﬀer or an
irrelevant serum for negative control tissues.
2.4. Quantitative Immunoﬂuorescent Imaging and Analysis.
Digital images for photomicroscopy were acquired through
AxioCam HRm camera (Carl Zeiss, Germany) with an
AxioVert 200M inverted microscope by Zeiss (Germany)
at ×200 magniﬁcation (Plan Neoﬂuar ×20 objective, 1.3
numerical aperture). Three-dimensional (3D) images were
captured through ApoTome optical sectioning methodol-
ogy (Carl Zeiss). Each 3D image consisted of 6–10 two-
dimensional (2D) images and the distance between Z-stack
slices was 1.225μm optimised by Nyquist. A minimum of
nine 3D images were randomly captured per mouse, which
include 5 images within the cortex (CTX) and 2 images each
from brainstem (BS) and hippocampal formation (HPF).
Cerebrovascular leakage of plasma protein apo B was
quantiﬁed within the CTX excluding the hippocampus, BS,
and HPF. The pixel intensity of the protein of interest for
each 3D image was calculated utilising the automated optical
intensitymeasurementtoolinVolocity(Softwareversion5.5,
Perkin Elmer, Melbourne, Australia) and expressed as per
unit volume. The investigator was blinded during imaging
and quantitation.
2.5. Plasma Cholesterol, Triglyceride, and NEFA. Plasma
cholesterol and triglycerides were determined in duplicate
by enzymatic assays (Randox Laboratories LTD, UK). Non-
esteriﬁed fatty acids (NEFAs) were determined with NEFA-
C (ASC-ACOD method, Wako Pure Chemical Industries,
Osaka, Japan).
2.6. Plasma S100β Analysis. Plasma S100β is used as a
marker of cerebrovascular inﬂammation and was measured
using ELISA kits according to manufacturers’ instructions
(CosmoBio, Tokyo, Japan). Plasma S100β was measured
with 30μL of plasma sample or standard and incubated
in precoated microtitre well plates at 4◦C overnight. Plates
were then incubated with biotinylated secondary antibody
and Streptavidin-HRP for 2h, each. Colour generated with
substrate and optical density determined at 492nm. After
adjusting for sample dilution, ﬁnal concentrations of plasma
S100β were extrapolated from standard curve.
2.7. Statistical Analysis. This study utilised n = 6m i c ep e r
group and minimum of nine 3D images were captured per
mouse for detection of apo B leakage. Each 3D image was
constructed by stacking of sequential 2D images, therefore
generating 324–540 two-dimensional images per group. All4 International Journal of Vascular Medicine
Table 2: Eﬀects of various feeding regimens on plasma lipids in
wild-type (C57BL/6J) mice.
SFA 5m +LF 2m +DHA 2m
TG (mM) 0.39 ± 0.04 0.54 ± 0.03∗ 0.43 ± 0.04
TC (mM) 1.45 ± 0.23 1.69 ± 0.17 3.11 ± 0.12∗∗
NEFA (mEq/L) 0.42 ± 0.03 0.45 ± 0.03 0.53 ± 0.05
Body weight
Final 25.65 ± 0.64 23.72 ± 0.96 20.21 ± 0.50∗∗
Weight gain 8.41 ± 0.51 5.7 ± 1.12 3.3 ± 0.51∗∗
Plasma total cholesterol (TC), triglycerides (TGs), and non-esteriﬁed fatty
acids (NEFAs) were measured at the end of the feeding regimen in mice
fed saturated fats (SFA 5m) and SFA-fed mice switched to an LF (+LF 2m)
and DHA diet (+DHA 2m). Final body weight and weight gain were also
calculated.Datarepresentedasmean±standarderrorofmean.Meanswere
compared with one-way ANOVA, where P<0.05 considered statistically
signiﬁcant (∗).
data was analysed by either parametric or nonparametric
one-way Analysis of Variance to assess the main eﬀects of LF
andDHAondietarySFA-inducedblood-brainbarrier(BBB)
dysfunction and their two-way interactions. Post-hoc com-
parison of means was done if the associated main eﬀect or
interaction was statistically signiﬁcant within the Analysis




HPF extravasation of apo B lipoproteins in WT mice main-
tained on an SFA diet for a total of 5 months (3 months
plus randomization to SFA for an additional 2 months:
Figures 1 and 2). Mice randomized to an LF diet following
3 months of SFA feeding had comparable levels of paren-
chymal apo B lipoprotein abundance to mice maintained on
SFA feeding alone (Figures 1 and 2). However, in mice ran-
domized to the DHA-enriched diet following 3 months of
SFA feeding, parenchymal apo B abundance was markedly
increased (Figures 1 and 2). The cerebrovascular eﬀects of
the DHA diet occurred commensurate with a 2-fold increase
in plasma cholesterol compared to mice maintained on the
SFA diet (Table 2). In contrast, the LF diet had no signif-
icant impact on plasma lipid homeostasis. Disturbances in
BBB integrity and function were supported by the ﬁnd-
ings of substantially increased plasma S100β in the SFA→
DHA mice compared to SFA alone (Figure 3). The protein
S100β is commonly used as a surrogate marker of brain-to-
blood leakage. The S100β is a cytokine produced exclusively
by the astrocytes of the central nervous system. Following
randomization, diﬀerences in food consumption were iden-
tiﬁed. Mice maintained on SFA or randomized to the LF
consumed on average 3g/day, whereas consumption of the
DHA-enriched diet was reduced to 2g/day. The lower caloric
intake of mice on the DHA enriched diet resulted in a slower








Figure 1:Three-Dimmunoﬂuorescent stainingofcerebral extrava-
sation of apo B. Parenchymal leakage of apo B lipoproteins (red) is
observed surrounding the cerebral microvessels. Nuclei are shown
in blue. The 3D images are from mice maintained on saturated-fat
diet for 5 months (SFA 5m) and SFA fed mice randomised to LF
(+LF 2m) and DHA (+DHA 2m) diet for further 2 months. Scale:
1 unit = 42.7μm.
4. Discussion
This study was designed to explore if provision of a diet
enriched in DHA attenuated cerebrovascular dysfunction
induced by chronic ingestion of an SFA diet. The primary
outcome measure was to determine the abundance of brain
parenchymal apo B lipoproteins that transport signiﬁcant
endogenous Aβ. Cerebral capillary vessels normally have
tightly apposed endothelial cells that ordinarily prevent
transport of plasma proteins and macromolecules [34].
The primary ﬁnding of this study showed that provision
of a PUFA diet principally enriched in DHA exacerbated
brain parenchymal extravasation of apo B lipoproteins that
had been initially induced by chronic ingestion of SFA. Pre-
viousstudiesexploringtheeﬀectoncerebrovascularintegrityInternational Journal of Vascular Medicine 5
Apo B










































Figure 2: Three-dimensional (3D) quantitative analysis of apo B
leakage in C57BL/6J mouse brain. Pixel intensity of apo B lipo-
proteins surrounding the cerebrovasculature was quantitated in 3D
images from mice maintained on saturated-fat diet for 5 months
( S F A5m )a n dS F A - f e dm i c era n d o m i s e dt oL F( + L F2m )a n dD H A
(+DHA 2m) diet for further 2 months. The extent of apo B pixel
intensity was measured in the cortex (CTX), brain stem (BS), and
hippocampal formation (HPF) and expressed as per unit volume.
The bars represent mean intensity and standard error of mean,
where P<0.05 considered statistically signiﬁcant (∗ Kruskal Wallis
t-test). The C57BL/6J mice randomised to DHA diet (+DHA) had
elevated apo B intensities in all regions of the brain.
and function by the SFA and PUFA diets described here, as
well as an MUFA-enriched diet, showed in C57BL/6J mice
that only the SFA diet induced parenchymal accumulation of
apo B lipoproteins [28]. Therefore, the paradoxical eﬀects of
the PUFA diet are likely to be a consequence of ampliﬁcation
of proinﬂammatory pathways induced as a consequence of
chronic SFA ingestion. Consistent with this concept, SFA-fed
mice randomized to an LF diet showed similar parenchymal
apo B abundance and plasma S100β as mice that were main-
tained on SFA alone.
Several studies have provided evidence of a vasoactive
role of Aβ, with pathological manifestations prior to Aβ
deposition. Exogenous administration of Aβ is vasoconstric-
tive and vessels treated with Aβ show signiﬁcant endothelial
cell damage with changes in the cell membrane, cytoplasm,
nucleus, and other organelles [16]. Takechi et al. [28] sug-
gested that that chronic ingestion of SFA may increase TRL-
Aβ secretion and that repeated postprandial excursions may
eventually disrupt BBB function. Consistent with this pos-
sibility, SFAs were shown to stimulate enterocytic Aβ abun-
dance and released into the circulation associated with post-
prandial TRL and a similar phenomenon may also occur in
liver [20, 35]. Moreover, diets enriched in SFA reduce high
aﬃnityclearancepathwaysofTRL-remnantlipoproteins and
this may contribute to increased postprandial lipaemia and
plasma Aβ [36, 37].
In this study, parenchymal apo B abundance did not
correlate with plasma triglyceride concentration. Mice fed
the DHA-enriched diet had comparable triglycerides to the
S100β


























Figure 3: Eﬀect of dietary fatty acids on plasma S100β con-
centration in C57BL/6J mice. The brain abundant protein S100β
was measured in plasma as a surrogate marker of BBB leakage.
High plasma S100β concentration in SFA-fed mice correlate with
signiﬁcant BBB dysfunction. In comparison to SFA 5m group,
plasma S100β was signiﬁcantly increased in mice switched to
the DHA diet (+DHA 2m). The bars represent mean plasma
concentration (pg/mL) and standard error of mean, where P<0.05
considered statistically signiﬁcant (∗ one-way ANOVA).
SFA group and plasma triglycerides were greatest in SFA
mice randomized to LF. Saturated fats often increase plasma
NEFA concentration compared to low-fat diets, whereas
DHA generally accelerates TRL clearance by facilitating LPL-
mediated lipolysis [38, 39]. However, in this study, there was
no signiﬁcant increase in net concentration of plasma NEFA
in mice randomized to the DHA diet versus those main-
tained on SFA alone (0.53 ± 0.05 versus 0.42 ± 0.03mEq/L,
resp.). Nonetheless, a role of fatty acids in modulating cere-
brovascular integrity cannot be ruled out because fatty acid
phenotype may be critically important. Many studies suggest
signiﬁcant vascular eﬀects of fatty acids. Human aortic
endothelial cells treated with TRL and lipoprotein lipase
(LPL)werehighlypermeable,whilstcellstreatedwithTRLor
LPL alone were not [40]. Furthermore, LPL-mediated TRL
lipolysis initiated degradation of the tight junction protein
ZO-1 and induced an endothelial apoptotic cascade.
The most signiﬁcant lipid eﬀect of randomization to
DHA following chronic ingestion of SFA in this study was a
twofold increase in plasma cholesterol compared to the mice
maintained on the SFA diet, or mice randomied to the LF
diet. A number of animal and clinical studies have shown
that DHA-enriched diets can increase plasma cholesterol
associated with low- and high-density lipoproteins [41–43].
Hypercholesterolemia has been associated with many vas-
culature abnormalities including endothelial dysfunction,
decreasedvascularreactivity,andenhancedexpressionofad-
hesionmolecules[44,45].Cellculturestudiessuggestseveral
mechanisms by which cholesterol may be pro-inﬂammatory
and some of these appear to be analogous to the eﬀects
of dietary SFA. Yao and colleagues reported that excess
cholesterolcausesendoplasmicreticulumandmitochondrial
stress that can lead to apoptosis [46]. Mitochondrial activity
or microsomal processing also results in the production6 International Journal of Vascular Medicine
of oxidized lipids that trigger and exacerbate inﬂammatory
pathways [47].
The anti-inﬂammatory properties of particularly the n3
and n6 fatty acids have been unequivocally demonstrated in
many studies. However, the propensity for PUFA to oxidize
may under some circumstances amplify oxidative stress
sequelae. Diets enriched in SFA enhance oxidation as a con-
sequence of stimulated mitochondrial function in activated
macrophages[46].DietarySFAdiminishtheproperfunction
of the cerebrovascular endothelial cells and are thereafter
likely to activate astro-glial cells which encompass cerebral
capillary vessels. It’s plausible that enhanced interaction of
plasma PUFA’s in DHA-fed mice with activated inﬂamma-
tory cells may be a primary mechanism by which the eﬀects
of SFA are ampliﬁed. Consistent with this possibility, Kuo
et al. [48] showed a dose eﬀect of dietary DHA on BBB
permeability in mice supplemented with 12% ﬁsh oil for 6
months, versus mice fed 3% ﬁsh oil. Similarly, rats consum-
ing ﬁsh oil exhibited increased lipid peroxidation [49, 50]
and oxidative stress-induced damage of DNA in the absence
of dietary antioxidants [51]. In vitro, DHA and EPA en-
hanced lipid peroxidation and triggered cellular apoptosis
[52, 53].
5. Summary
Chronic ingestion of diets enriched in SFA commonly causes
vascular dysfunction, including in capillary vessels of the
brain. The eﬀects of SFA could be described as a response-
to-injury phenomenon induced by exaggerated exposure to
plasma triglyceride, cholesterol, NEFA, or harmful inﬂam-
matoryproductsoflipidmetabolism,suchaslipidperoxides.
Many studies support a role of n3 and n6 fatty acids in the
prevention of vascular, based disorders primarily via sup-
pressionofinﬂammatorycascades.Lessclearhoweverarethe
beneﬁts of polyunsaturated oils in the presence of profound
inﬂammation, because of the propensity to generate lipid
peroxidation products.
In an established model of cerebrovascular dysfunction
induced by chronic ingestion of an SFA-enriched diet, pro-
visionofDHAampliﬁedtheharmfuleﬀects.Probablemech-
anisms include hypercholesterolemia and perhaps fatty acid-
induced cytotoxicity. The data suggests that introduction of
n3/n6 fatty acids in metabolic conditions that are charac-
terized by heightened systemic inﬂammation needs to be
carefully considered in the context of paradoxical detrimen-
tal eﬀects that could occur.
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